HEADER HYDROLASE 25-NOV-22 8BSM TITLE HUMAN GLS IN COMPLEX WITH COMPOUND 18 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL 65 KDA CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: KIDNEY; SOURCE 6 GENE: GLS, GLS1, KIAA0838; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HYDROLASE, GLUTAMINASE, THIADIAZOLE, PYRIDAZINE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI REVDAT 1 18-JAN-23 8BSM 0 JRNL AUTH M.R.V.FINLAY,M.ANDERTON,A.BAILEY,S.BOYD,J.BROOKFIELD, JRNL AUTH 2 C.CAIRNDUFF,M.CHARLES,A.CHEASTY,S.E.CRITCHLOW,J.CULSHAW, JRNL AUTH 3 T.EKWURU,I.HOLLINGSWORTH,N.JONES,F.LEROUX,M.LITTLESON, JRNL AUTH 4 H.MCCARRON,J.MCKELVIE,L.MOONEY,J.W.M.NISSINK,D.PERKINS, JRNL AUTH 5 S.POWELL,M.J.QUESADA,P.RAUBO,V.SABIN,J.SMITH,P.D.SMITH, JRNL AUTH 6 A.STARK,A.TING,P.WANG,Z.WILSON,J.J.WINTER-HOLT,J.M.WOOD, JRNL AUTH 7 G.L.WRIGLEY,G.YU,P.ZHANG JRNL TITL DISCOVERY OF A THIADIAZOLE-PYRIDAZINE-BASED ALLOSTERIC JRNL TITL 2 GLUTAMINASE 1 INHIBITOR SERIES THAT DEMONSTRATES ORAL JRNL TITL 3 BIOAVAILABILITY AND ACTIVITY IN TUMOR XENOGRAFT MODELS. JRNL REF J MED CHEM V. 62 6540 2019 JRNL REFN ISSN 1520-4804 JRNL PMID 31199640 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00260 REMARK 2 REMARK 2 RESOLUTION. 2.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 19746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1010 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.78 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2939 REMARK 3 BIN FREE R VALUE : 0.3084 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 15 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2348 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 112 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.11700 REMARK 3 B22 (A**2) : 8.11700 REMARK 3 B33 (A**2) : -16.23400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.299 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.219 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.285 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.216 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.925 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2465 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3337 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 829 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 415 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2465 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 303 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1756 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.81 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.49 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.01 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -7.199 15.5401 23.5427 REMARK 3 T TENSOR REMARK 3 T11: 0.0045 T22: -0.1934 REMARK 3 T33: -0.027 T12: 0.0219 REMARK 3 T13: 0.0258 T23: -0.0461 REMARK 3 L TENSOR REMARK 3 L11: 1.2993 L22: 2.0192 REMARK 3 L33: 1.3822 L12: 0.0141 REMARK 3 L13: 0.2496 L23: 0.1658 REMARK 3 S TENSOR REMARK 3 S11: -0.0467 S12: 0.2654 S13: 0.0213 REMARK 3 S21: 0.2654 S22: 0.0454 S23: -0.105 REMARK 3 S31: 0.0213 S32: -0.105 S33: 0.0013 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8BSM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1292127012. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19775 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.780 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.10 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.70 REMARK 200 R MERGE FOR SHELL (I) : 0.60800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8M LITHIUM SULPHATE 0.1M BISTRIS PH REMARK 280 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 -X+1/2,Y,-Z+3/4 REMARK 290 6555 X,-Y+1/2,-Z+1/4 REMARK 290 7555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X,-Y,Z REMARK 290 11555 -Y+1/2,X,Z+3/4 REMARK 290 12555 Y,-X+1/2,Z+1/4 REMARK 290 13555 -X,Y+1/2,-Z+1/4 REMARK 290 14555 X+1/2,-Y,-Z+3/4 REMARK 290 15555 Y,X,-Z REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 69.96400 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.04650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.02325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 69.96400 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 117.06975 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 117.06975 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 69.96400 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.02325 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 69.96400 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 78.04650 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 69.96400 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 78.04650 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 69.96400 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 117.06975 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 39.02325 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 69.96400 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 39.02325 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 117.06975 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 69.96400 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 69.96400 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 78.04650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A 602 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 760 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 219 REMARK 465 MET A 220 REMARK 465 ILE A 221 REMARK 465 LEU A 316 REMARK 465 ARG A 317 REMARK 465 PHE A 318 REMARK 465 ASN A 319 REMARK 465 LEU A 533 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 383 CG CD OE1 OE2 REMARK 470 GLU A 403 CD OE1 OE2 REMARK 470 LYS A 507 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 223 98.65 -69.69 REMARK 500 GLN A 285 -120.69 58.92 REMARK 500 LYS A 346 59.04 38.51 REMARK 500 TYR A 466 -135.77 54.98 REMARK 500 VAL A 495 -63.58 -132.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 808 DISTANCE = 7.95 ANGSTROMS REMARK 525 HOH A 809 DISTANCE = 8.19 ANGSTROMS REMARK 525 HOH A 810 DISTANCE = 14.30 ANGSTROMS REMARK 525 HOH A 811 DISTANCE = 16.84 ANGSTROMS REMARK 525 HOH A 812 DISTANCE = 21.18 ANGSTROMS DBREF 8BSM A 221 533 UNP O94925 GLSK_HUMAN 221 533 SEQADV 8BSM SER A 219 UNP O94925 EXPRESSION TAG SEQADV 8BSM MET A 220 UNP O94925 EXPRESSION TAG SEQRES 1 A 315 SER MET ILE PRO ASP PHE MET SER PHE THR SER HIS ILE SEQRES 2 A 315 ASP GLU LEU TYR GLU SER ALA LYS LYS GLN SER GLY GLY SEQRES 3 A 315 LYS VAL ALA ASP TYR ILE PRO GLN LEU ALA LYS PHE SER SEQRES 4 A 315 PRO ASP LEU TRP GLY VAL SER VAL CYS THR VAL ASP GLY SEQRES 5 A 315 GLN ARG HIS SER THR GLY ASP THR LYS VAL PRO PHE CYS SEQRES 6 A 315 LEU GLN SER CYS VAL LYS PRO LEU LYS TYR ALA ILE ALA SEQRES 7 A 315 VAL ASN ASP LEU GLY THR GLU TYR VAL HIS ARG TYR VAL SEQRES 8 A 315 GLY LYS GLU PRO SER GLY LEU ARG PHE ASN LYS LEU PHE SEQRES 9 A 315 LEU ASN GLU ASP ASP LYS PRO HIS ASN PRO MET VAL ASN SEQRES 10 A 315 ALA GLY ALA ILE VAL VAL THR SER LEU ILE LYS GLN GLY SEQRES 11 A 315 VAL ASN ASN ALA GLU LYS PHE ASP TYR VAL MET GLN PHE SEQRES 12 A 315 LEU ASN LYS MET ALA GLY ASN GLU TYR VAL GLY PHE SER SEQRES 13 A 315 ASN ALA THR PHE GLN SER GLU ARG GLU SER GLY ASP ARG SEQRES 14 A 315 ASN PHE ALA ILE GLY TYR TYR LEU LYS GLU LYS LYS CYS SEQRES 15 A 315 PHE PRO GLU GLY THR ASP MET VAL GLY ILE LEU ASP PHE SEQRES 16 A 315 TYR PHE GLN LEU CYS SER ILE GLU VAL THR CYS GLU SER SEQRES 17 A 315 ALA SER VAL MET ALA ALA THR LEU ALA ASN GLY GLY PHE SEQRES 18 A 315 CYS PRO ILE THR GLY GLU ARG VAL LEU SER PRO GLU ALA SEQRES 19 A 315 VAL ARG ASN THR LEU SER LEU MET HIS SER CYS GLY MET SEQRES 20 A 315 TYR ASP PHE SER GLY GLN PHE ALA PHE HIS VAL GLY LEU SEQRES 21 A 315 PRO ALA LYS SER GLY VAL ALA GLY GLY ILE LEU LEU VAL SEQRES 22 A 315 VAL PRO ASN VAL MET GLY MET MET CYS TRP SER PRO PRO SEQRES 23 A 315 LEU ASP LYS MET GLY ASN SER VAL LYS GLY ILE HIS PHE SEQRES 24 A 315 CYS HIS ASP LEU VAL SER LEU CYS ASN PHE HIS ASN TYR SEQRES 25 A 315 ASP ASN LEU HET SO4 A 601 5 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET 5XX A 606 36 HETNAM SO4 SULFATE ION HETNAM 5XX 2-PHENYL-~{N}-[5-[[(3~{R})-1-[5-(2- HETNAM 2 5XX PHENYLETHANOYLAMINO)-1,3,4-THIADIAZOL-2-YL]PYRROLIDIN- HETNAM 3 5XX 3-YL]AMINO]-1,3,4-THIADIAZOL-2-YL]ETHANAMIDE FORMUL 2 SO4 5(O4 S 2-) FORMUL 7 5XX C24 H24 N8 O2 S2 FORMUL 8 HOH *112(H2 O) HELIX 1 AA1 ASP A 223 LYS A 240 1 18 HELIX 2 AA2 ILE A 250 LYS A 255 1 6 HELIX 3 AA3 GLN A 285 CYS A 287 5 3 HELIX 4 AA4 VAL A 288 HIS A 306 1 19 HELIX 5 AA5 VAL A 334 SER A 343 1 10 HELIX 6 AA6 ASN A 350 GLY A 367 1 18 HELIX 7 AA7 SER A 374 GLY A 385 1 12 HELIX 8 AA8 GLY A 385 LYS A 398 1 14 HELIX 9 AA9 ASP A 406 SER A 419 1 14 HELIX 10 AB1 THR A 423 ASN A 436 1 14 HELIX 11 AB2 SER A 449 GLY A 464 1 16 HELIX 12 AB3 MET A 465 ASP A 467 5 3 HELIX 13 AB4 PHE A 468 VAL A 476 1 9 HELIX 14 AB5 SER A 511 ASN A 526 1 16 SHEET 1 AA1 2 LYS A 245 VAL A 246 0 SHEET 2 AA1 2 PRO A 504 LEU A 505 -1 O LEU A 505 N LYS A 245 SHEET 1 AA2 5 ARG A 272 GLY A 276 0 SHEET 2 AA2 5 GLY A 262 THR A 267 -1 N VAL A 265 O HIS A 273 SHEET 3 AA2 5 MET A 496 TRP A 501 -1 O GLY A 497 N CYS A 266 SHEET 4 AA2 5 GLY A 487 VAL A 492 -1 N VAL A 492 O MET A 496 SHEET 5 AA2 5 ALA A 480 SER A 482 -1 N LYS A 481 O LEU A 489 SHEET 1 AA3 3 PHE A 282 CYS A 283 0 SHEET 2 AA3 3 ILE A 420 VAL A 422 -1 O VAL A 422 N PHE A 282 SHEET 3 AA3 3 GLY A 372 PHE A 373 -1 N GLY A 372 O GLU A 421 CRYST1 139.928 139.928 156.093 90.00 90.00 90.00 I 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007147 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007147 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006406 0.00000